CMMAd

Autologous adipose-derived mesenchymal stem cells · Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMMAd, covering 2018-04-17 to 2018-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence [Phase 1, Phase 2]

See pricing